Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Apalla

Showing results (161-170 of 226) with videos related to

Pageof 23
Sort By:
European Journal of Dermatology : EJD|December 22, 2021
How to spot a basosquamous carcinoma: a study on demographics, clinical-dermatoscopic features and histopathological correlationsDimitrios Sgouros, Zoe Apalla, Melpomeni Theofili, et al.
Dermatology Practical & Conceptual|March 9, 2023
Narrative Review of Drug-Associated Nail Toxicities in Oncologic PatientsAnastasia Emvalomati, Valentina Oflidou, Chryssoula Papageorgiou, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2014
Twenty nevi on the arms: a simple rule to identify patients younger than 50 years of age at higher risk for melanomaGiuseppe Argenziano, Jason Giacomel, Iris Zalaudek, et al.
Journal of Clinical Medicine|February 11, 2023
Dermoscopy of Actinic Keratosis: Is There a True Differentiation between Non-Pigmented and Pigmented Lesions?Dimitrios Sgouros, Melpomeni Theofili, Theodora Zafeiropoulou, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Distribution of the dermoscopic features of melanoma of trunk and extremities according to the anatomic sublocationJuta Maskalane, Eliza Salijuma, Konstantinos Lallas, et al.
Frontiers in Immunology|February 17, 2025
Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysisKonstantinos Lallas, Eftychia Chatziioannou, Derya Durak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2025
Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patientsMatilde Iorizzo, Francesca Pampaloni, Zoe Apalla, et al.
Journal of the American Academy of Dermatology|September 10, 2019
Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoringAimilios Lallas, Zoe Apalla, Athanassios Kyrgidis, et al.
International Journal of Dermatology|September 10, 2025
Clinical and Dermoscopic Characterization of Scalp Cutaneous Metastases From Breast Carcinoma: A Multicenter Study of the EADV Task Force on Hair DiseasesAndrea Sechi, Jacopo Tartaglia, Monica Ponzano, et al.
Dermatology Practical & Conceptual|August 9, 2024
The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients Quality of Life and the Role of Dermatologic InterventionChristina Kemanetzi, Konstantinos Lallas, Elizavet Lazaridou, et al.
Pageof 23

Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
European Journal of Dermatology : EJD|December 22, 2021
How to spot a basosquamous carcinoma: a study on demographics, clinical-dermatoscopic features and histopathological correlationsDimitrios Sgouros, Zoe Apalla, Melpomeni Theofili, et al.
Dermatology Practical & Conceptual|March 9, 2023
Narrative Review of Drug-Associated Nail Toxicities in Oncologic PatientsAnastasia Emvalomati, Valentina Oflidou, Chryssoula Papageorgiou, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2014
Twenty nevi on the arms: a simple rule to identify patients younger than 50 years of age at higher risk for melanomaGiuseppe Argenziano, Jason Giacomel, Iris Zalaudek, et al.
Journal of Clinical Medicine|February 11, 2023
Dermoscopy of Actinic Keratosis: Is There a True Differentiation between Non-Pigmented and Pigmented Lesions?Dimitrios Sgouros, Melpomeni Theofili, Theodora Zafeiropoulou, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Distribution of the dermoscopic features of melanoma of trunk and extremities according to the anatomic sublocationJuta Maskalane, Eliza Salijuma, Konstantinos Lallas, et al.
Frontiers in Immunology|February 17, 2025
Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysisKonstantinos Lallas, Eftychia Chatziioannou, Derya Durak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2025
Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patientsMatilde Iorizzo, Francesca Pampaloni, Zoe Apalla, et al.
Journal of the American Academy of Dermatology|September 10, 2019
Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoringAimilios Lallas, Zoe Apalla, Athanassios Kyrgidis, et al.
International Journal of Dermatology|September 10, 2025
Clinical and Dermoscopic Characterization of Scalp Cutaneous Metastases From Breast Carcinoma: A Multicenter Study of the EADV Task Force on Hair DiseasesAndrea Sechi, Jacopo Tartaglia, Monica Ponzano, et al.
Dermatology Practical & Conceptual|August 9, 2024
The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients Quality of Life and the Role of Dermatologic InterventionChristina Kemanetzi, Konstantinos Lallas, Elizavet Lazaridou, et al.
Pageof 23